OSU-03012, an inhibitor of GRP94 and GRP78, has been demonstrated to exhibit anti-cancer effects in combination with sildenafil, a well-known selective phosphodiesterase type 5 (PDE5) inhibitor [268,269]. Here, HSP90B1 is linked to cancer.